B+
Bull case
25%
Probability
Target price
$7.50
+11.3% vs current
TBI
TrueBlueBNYSE / Commercial & Professional Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$6.25
-7.3% vs current
B-
Bear case
25%
Probability
Target price
$4.75
-29.5% vs current
AI sentiment snapshot
Latest data as of 2026-05-08
Recent news sentiment (30D)
+0.1
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+40.4
Score
AI commentary
This is still a cautious monitoring setup rather than a high-conviction re-rate call. Company-source earnings evidence improved the thesis quality, but the T+3 follow-up still shows limited outside analyst revision evidence, and secondary coverage described only a modest initial post-earnings move. With shares at $5.93 on May 8 versus the $6.01 May 7 anchor, the market appears to be waiting for proof that revenue stabilization can convert into cleaner margins and cash generation.
RankAlpha Sentiment Codex - 2026-05-08
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-06eventRights agreement expiration reduces one governance overhang but does not fix operationsMedium impact
On May 6, 2026, TrueBlue amended its rights agreement to move the final expiration date to May 6, 2026, effectively ending the rights plan immediately. That may slightly reduce governance friction around the activist situation, but the filing does not itself change operating fundamentals, so the market impact is likely secondary to execution on revenue quality and margins. [#8-K-2026-05-06]
2026-05-08catalystQ1 print showed growth stabilization but only a muted post-earnings reactionMedium impact
TrueBlue's Q1 results showed revenue of $399 million, up 8% year over year with 7% organic growth, while net loss widened to $20 million and adjusted EBITDA improved only modestly to negative $3 million. Gross margin was pressured by lower workers' compensation reserve benefit and business mix, so the print supports a stabilization thesis more than a clean earnings-turn thesis. Primary company materials confirmed the release and outlook, but by May 8 the stock was still near the May 7 anchor, suggesting the market reaction remained modest rather than decisive. [#8-K-2026-05-05][#10-Q-2026-05-05]
2026-06-30catalystQ2 revenue guide still needs to overcome margin headwindsHigh impact
Management guided Q2 revenue to $405 million to $430 million, or about 2% to 8% year-over-year growth, assuming current market conditions continue and growth persists across skilled businesses. However, the same company presentation guided to another year-over-year gross-margin decline because prior workers' compensation reserve benefits and government subsidy benefits are not expected to repeat, keeping profitability recovery as the main execution test. [#8-K-2026-05-05]
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-08 • Updated nightlySource: Internal modelMethodology